Boehringer Ingelheim yesterday announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai.
ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health. ARTES Biotechnology specialises in recombinant protein production, process and vaccine development from microbial expression systems. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ METAVAX® platform, this offers a new, unique and economical approach to low-cost mass production of safe and effective vaccines required in the veterinary field.
US – Governor Terry E. Branstad travelled to Sioux Center last week to attend the grand opening for one of three Boehringer Ingelheim Vetmedica, Inc. (BIVI) specialised vaccine research facilities.
BARCELONA, SPAIN - An important anniversary in the history of porcine circovirus type 2 (PCV2) has been marked at a special international pig veterinary satellite symposium held in Barcelona, Spain in June 2011 as part of the 6th International Symposium on Emerging and Re-emerging Pig Diseases.
Because hypothermic pigs
require more time after birth to ingest adequate colostrum
generally ingest less colostrum
At the start of life every single gram of bodyweight counts:
110 g higher start weight...
...means in this farm a 620g higher weaning weight
US - Many of the key lessons gained from area regional control (ARC) programme targeted at PRRS virus over the last six years are now being used to help producers manage, monitor and share information on other swine diseases, including porcine epidemic diarrhoea (PED) and influenza, says Boehringer Ingelheim Vetmedica Inc. (BIVI).
Get the latest news on Swine Health Subscribe to our newsletter